Metabolomic Data Profiling for Diabetes Research in Qatar

Author(s):  
Raghvendra Mall ◽  
Laure Berti-Equille ◽  
Halima Bensmail
2011 ◽  
Vol 6 (S 01) ◽  
Author(s):  
M Lucio ◽  
R Lehmann ◽  
HU Häring ◽  
P Schmitt-Kopplin

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 209-OR ◽  
Author(s):  
ANA MARIA ARBELAEZ ◽  
STEFANI O’DONOGHUE ◽  
NELLY MAURAS ◽  
BRUCE A. BUCKINGHAM ◽  
NEIL H. WHITE ◽  
...  

2013 ◽  
Vol 01 (01) ◽  
pp. 006-008
Author(s):  
Heather Stuckey

Qualitative research is a primary way to understand the context of diabetes in a person′s life, beyond the medical outcomes. Identifying the qualitative issues such as patients′ knowledge about diabetes, their beliefs and attitudes, and their relationship with health care professionals can serve as data to determine the obstacles and, in turn, resolutions to those issues in diabetes management. Characteristics of qualitative and quantitative methods are described, with the discussion that both methods are complementary, not conflicting, to further the field of diabetes research.


Author(s):  
Kevin Bellofatto ◽  
Beat Moeckli ◽  
Charles-Henri Wassmer ◽  
Margaux Laurent ◽  
Graziano Oldani ◽  
...  

Abstract Purpose of Review β cell replacement via whole pancreas or islet transplantation has greatly evolved for the cure of type 1 diabetes. Both these strategies are however still affected by several limitations. Pancreas bioengineering holds the potential to overcome these hurdles aiming to repair and regenerate β cell compartment. In this review, we detail the state-of-the-art and recent progress in the bioengineering field applied to diabetes research. Recent Findings The primary target of pancreatic bioengineering is to manufacture a construct supporting insulin activity in vivo. Scaffold-base technique, 3D bioprinting, macro-devices, insulin-secreting organoids, and pancreas-on-chip represent the most promising technologies for pancreatic bioengineering. Summary There are several factors affecting the clinical application of these technologies, and studies reported so far are encouraging but need to be optimized. Nevertheless pancreas bioengineering is evolving very quickly and its combination with stem cell research developments can only accelerate this trend.


2021 ◽  
pp. 2001183
Author(s):  
Orla Prendiville ◽  
Janette Walton ◽  
Albert Flynn ◽  
Anne P. Nugent ◽  
Breige A. McNulty ◽  
...  

2020 ◽  
Vol 36 (Supplement_2) ◽  
pp. i787-i794
Author(s):  
Gian Marco Messa ◽  
Francesco Napolitano ◽  
Sarah H. Elsea ◽  
Diego di Bernardo ◽  
Xin Gao

Abstract Motivation Untargeted metabolomic approaches hold a great promise as a diagnostic tool for inborn errors of metabolisms (IEMs) in the near future. However, the complexity of the involved data makes its application difficult and time consuming. Computational approaches, such as metabolic network simulations and machine learning, could significantly help to exploit metabolomic data to aid the diagnostic process. While the former suffers from limited predictive accuracy, the latter is normally able to generalize only to IEMs for which sufficient data are available. Here, we propose a hybrid approach that exploits the best of both worlds by building a mapping between simulated and real metabolic data through a novel method based on Siamese neural networks (SNN). Results The proposed SNN model is able to perform disease prioritization for the metabolic profiles of IEM patients even for diseases that it was not trained to identify. To the best of our knowledge, this has not been attempted before. The developed model is able to significantly outperform a baseline model that relies on metabolic simulations only. The prioritization performances demonstrate the feasibility of the method, suggesting that the integration of metabolic models and data could significantly aid the IEM diagnosis process in the near future. Availability and implementation Metabolic datasets used in this study are publicly available from the cited sources. The original data produced in this study, including the trained models and the simulated metabolic profiles, are also publicly available (Messa et al., 2020).


2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Daniel J. Panyard ◽  
Kyeong Mo Kim ◽  
Burcu F. Darst ◽  
Yuetiva K. Deming ◽  
Xiaoyuan Zhong ◽  
...  

AbstractThe study of metabolomics and disease has enabled the discovery of new risk factors, diagnostic markers, and drug targets. For neurological and psychiatric phenotypes, the cerebrospinal fluid (CSF) is of particular importance. However, the CSF metabolome is difficult to study on a large scale due to the relative complexity of the procedure needed to collect the fluid. Here, we present a metabolome-wide association study (MWAS), which uses genetic and metabolomic data to impute metabolites into large samples with genome-wide association summary statistics. We conduct a metabolome-wide, genome-wide association analysis with 338 CSF metabolites, identifying 16 genotype-metabolite associations (metabolite quantitative trait loci, or mQTLs). We then build prediction models for all available CSF metabolites and test for associations with 27 neurological and psychiatric phenotypes, identifying 19 significant CSF metabolite-phenotype associations. Our results demonstrate the feasibility of MWAS to study omic data in scarce sample types.


Sign in / Sign up

Export Citation Format

Share Document